Kementec Solutions A/S: Financial statements 2019
CVR: 25806735
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Kementec Solutions A/S (CVR 25806735) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 16,361,313 and a net result of DKK 4,059,031 compared with DKK 2,818,717 the year before. That is an increase of 17.4% compared with the year before. Equity in the 2019 report amounted to DKK 10,081,831. The solvency ratio was 38%. The company had 19 employees in the financial year.
- Gross Profit
- DKK 16,361,313
- Profit/Loss
- DKK 4,059,031
- Equity
- DKK 10,081,831
- Total Assets
- DKK 26,542,343
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 16.4 mio. | 4.1 mio. | 10.1 mio. | 19 |
| 2018 | - | 13.9 mio. | 2.8 mio. | 6 mio. | 18 |
| 2017 | - | 13.5 mio. | 3.8 mio. | 3.2 mio. | 17 |
| 2016 | - | 13.4 mio. | 3.6 mio. | 7.4 mio. | 16 |
| 2015 | - | 14 mio. | 3.7 mio. | 6.3 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 26, 2019, Henrik Christensen has joined the board of directors of Kementec Solutions A/S.
As of September 26, 2019, Claas Thöle has left the board of directors of Kementec Solutions A/S.
On June 19, 2019, the company changed its name from KEM-EN-TEC DIAGNOSTICS A/S to Kementec Solutions A/S.
Kementec Solutions A/S has published its annual report for 2018. Gross profit came to DKK 13,932,862, and the net result was DKK 2,818,717.
About Kementec Solutions A/S
Kementec Solutions A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2000. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named KEM-EN-TEC DIAGNOSTICS A/S. The management consists of Elaine Antonette Lundberg and Tobias Greve-Vilby. The board consists of Frank Vitzthum (chair), Christian Moraeno Dreher and Ute Salzbrenner. The company is owned by R-Biopharm AG. The company has 20 employees (2026). In 2025, the company reported a gross profit of DKK 18,706,173 and a net result of DKK 2,269,339 compared with DKK 1,565,137 the year before. Equity in the 2025 report amounted to DKK 25,366,459.